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Junctional forms of epidermolysis bullosa OEB) are 
characterized by tissue separation at the level of the 
lamina Iucida. We have recently disclosed specific 
mutations in the LAMA3, LAMB3, and LAMC2 genes 
encoding the subunit polypeptides of the anchoring 
filament protein laminin 5 in 66 families with differ-
ent variants ofJEB. Examination oftheJEB mutation 
database revealed recurrence of a particular C~T 
substitution at nucleotide position 1903 (exon 14) of 
LAMB3, resulting in the mutation R635X. The inheri-
tance of this nonsense mutation was noted on diffe-
rent genetic backgrounds, suggesting that R635X is a 
hotspot mutation. In this study, we have performed 
mutation evaluation in a European cohort of 14 
families with the lethal, Herlitz type of JEB (H-JEB). 
The families were first screened for the presence of 
the R635X mutation by restriction enzyme digestion 
of the PCR product corresponding to exon 14. Four 
of the probands were found to be homozygous and six 
E pidermolysis bullosa (EB) is a group of heritable blis-tering skin diseases with considerable clinical and ge-netic variability. EB can be divided into three major categories on the basis of the level of tissue separation within the cutaneous basement membrane zone (Fine et 
al, 1991; Uitto and Christiano, 1992; Christiano a11d Uitto, 1996). 
In the junctional forms of EB QEB), the tissue separation occurs 
within the dermal-epidermal basem ent membrane at the level of 
the lamina Iucida. 
The characteris tic ultrastructural feature of JEB is abnormalities 
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were heterozygous for R635X. The remaining alleles 
were subjected to mutation screening by PCR ampli-
fication of individual exons of LAMB3 and LAMC2, 
followed by heteroduplex analysis and nucleotide 
sequencing. In three families (six alleles), mutations 
in LAMC2 were disclosed. In the remaining eight 
alleles, additional pathogenetic LAMB3 mutations 
were found. None of the patients had LAMA3 muta-
tion. Thus, LAMB3 mutations accounted for 22 of 28 
JEB alleles (79%), and a total of14 of22 LAMB3 alleles 
(64%) harbored the R635X mutation, signifying its 
prevalence as a predominant genetic lesion underly-
ing H-JEB in this European cohort of patients. This 
recurrent mutation will facilitate screening of addi-
tionalJEB patients for the purpose of prenatal testing 
of fetuses at risk for recurrence. Key words: basement 
membrane zone/laminin 5 mutations. J Invest Del'trratol 
109:232-237, 1997 
in the hemidesmosome-anchot-ing filament complex (Tidman and 
Eady, 1986). These attachment structures consist of several protein 
components, including the hemidesmosomal proteins, HD-1/plec-
tin, the 230-kDa and the 180-kDa bullous pemphigoid antigens 
(BPAG1 and BPAG2, respectively), and the a6{34 integrin, as well 
as the a11choring filament protein laminin 5 (Uitto et a/, 1994; 
Christiano and Uitto, 1996; Uitto and Pulkkinen, 1996) . The 
corresponding genes, therefore, serve as candidate genes for tnu-
tations in different forms of JEB. Accordingly, we have recently 
demonstrated specific mutations in all three genes (LAMA3, 
LAMB3, and LAMC2) encoding the constitutive polypeptide sub-
units of laminin 5, the a3, {33, a11d y2 chains (Uitto et al, 1994, 
1995; Christiano and Uitto, 1996; Uitto and Pulkkinen, 1996) . In 
addition, mutations in the a6 {34 integrin genes have been disclosed 
in a subset of]EB associated with pyloric atresia (Vidal et al, 1995; 
Uitto and Pulkkinen, 1996; Pulkkinen et a/, 1997a, 1997b; Tak.i-
zawa et al, 1997), and BPAG2 gene mutations have been demon-
strated in a nonlethal variant of JEB, generalized atrophic benign 
ep.idermolysis bullosa (Uitto and Pulkkinen, 1996). Finally, based 
on inununofluorescence and immunoblot analyses, HD-1/plectin 
0022-202X/97/$10.50 • Copyright © 1997 by T he Society for Investigative Dermatology, Inc. 
232 
VOL. 109, NO. 2 AUGUST 1997 MUTATIONS IN JEB 233 
Family 1 Family 2 Family 3 Family 4 Family 5 
1~11~11~1~1~1 
1-1 1-2 1-3 1-4 1-5 2-1 2-2 2-3 2-4 3-1 3-2 3-3 4-1 4-2 4-3 5-1 5-2 5-3 MW 
578 bp 
428 bp 
150 bp 
has been suggested to serve as a candidate gene/protein system in 
patients with EB associated with muscular dystrophy and depicting 
tissue separation at the level of hem.idesmosomes (Gache eta/, 1996; 
Uitto et al, 1996). Consequently, we have recently demonstrated 
mutations in the plectin gene i11 five families with EB associated 
with muscular dystrophy (see Uitto eta/, 1996). 
Examination of the reported mutations in the !an-linin 5 genes 
reveals tl1at a recurrent nonsense mutation , R 635X, accounts for 
46% of the LAMB3 mutations and of 38% of all laminin 5 gene 
mutations over all (see Kivliikko el a/, 1996, and Diswssion). In this 
study, we have undertaken a prospective mutation detection anal-
ysis of a cohort of 14 families of European origu1 with JEB. 
MATERIALS AND METHODS 
Clittical Fourteen families of European origin with the leth <tl (Herlitz) 
type of ]EB (H-JEB) were included in tlus study (Table I) . The diagnosis 
Was based on a combination of cli1ucal observations, immunofluorescence 
stauung witl1 a monoclonal antibody GB3 directed agaiJ1st lami1lli1 5 
(Verrando et a/, 1991), and/or ultrastructural examination of the skin by 
transmission electron microscopy. In each case, the paren ts were clinica lly 
U11affected. consistent with an autosomal recessive inheritan ce pattern. 
Genomic DNA for mutation analysis was isolated from peripheral blood 
leukocytes by standard techniques (Sambrook et a/, 1989). 
Screening for the Mutation R635X in LAMB3 T he mutation R.635X, 
refl ecting a C_,.T transition at nucleotide position 1903 of LAM133 
(Gerecke et. til , 1994; GenBank accession no. L25541 ), results in the 
generation of a new restriction enzyme site for Bglll (Pu lkkinen eta/, 1994). 
To screen for the presence of tlus mutation , ex on 14 sequences ofLAMB3 
were amplified from genonuc DNA with primers as described previously 
(Kivirikko et a/, 1996). Aliquots of tl1e polymerase ch ain reaction (PCR) 
products were subjected to Bg/II digestion using the manu£1cturer's recom-
mendations (New England Biolabs, Beverly, MA), and the digestion 
products were fractionated on 2% agarose gels. T he presence of the C-,>T 
substitution was reflected by digestion of the 578-bp PCR product to 
428-bp and 150-bp fragments. 
Heteroduplex Scanning of the LAMB3 and LAMC2 Genes for 
Mutations Total genomic DNA was used as template for PCR amplift-
cation of individual exons in the LAMB3 gene, as described previously 
Figure 1. Screening for the recurrent 
mutation R635X in the LAMB3 gene 
itt 11 European families with H-JEB. 
PCR products spanning exon 14 of the 
LAMB3 gene were digested with the re-
striction enzyme, Bg/II, followed by analy-
sis on 2% agarose gel. T he 578-bp band 
corresponds to the normal allele, which is 
digested to 428-bp and 150-bp bands in the 
mutant allele. 
(Pulkk.inen et a/ , 1995b). T he primers used for PCR. amplification were 
placed in adjacent in trons, and the individual PCR products contained 
sequences of each of the 22 exons encompassing the coding region of 
LAMB3 (Pulkkinen et a/, 1995a; for genonuc sequences, see GenBan k 
accession n os. U17744-17760). A similar mutation detection strategy was 
performed in the LAMC2 gene (Pulkkinen eta/, 1997c; GenBank accession 
nos. U31178-U31201). The PCR products were examined on 2% agarose 
gels and subjected to beteroduplex analysis for detection of sequence 
varian ts by conformation- sensitive gel electrophoresis (CSGE; Ganguly et al, 
1993 ). For CSGE, the pro bands' PCR. products were nuxed with an equal 
amount of ampli fied DNA from unafFected unrelated controls .in some cases, 
to allow detection of homozygous muta tions. If a PCR product of altered 
m obility was detected by heteroduplex analysis, the product was subjected 
to direct automated sequencing (Applied Biosystems, Foster City, CA) . 
Verification of the Mutations The mutations detected by he terodu-
plex analysis were verified from amplified genomic DNA in tl1e region of 
the mutation. Whenever possible, the PCR products were an alyzed by 
Table I . Families with H-JEB and Mutations in the 
LAMB3 Gene 
Na tionali ty/ 
Ethnic Exon s 
Family Ot~gin Mutation(s) Affected Verification " 
1 France 562-2A ._,. G/R635X 7''/14 N laiV/BglH 
2 France 565-2A->G/565-2A_,.G i'l 7b MaiV 
3 Sweden R635X/2910-1G->A 14/ 201' Bglll l Bsajl 
4 Belgium R.635X/R972X 14/20 Bglll l AlrvNI 
5 France 29insC/R 635X 3/14 A lwNII Bglll 
6 France Q243X/ R635X 8/14 Bsuifi /Bg!U 
7 France R635X/ R635X 14/14 Bg/II 
8 France R635X/ R635X 14/14 Bglll 
9 France C290X/R635X 9/14 ASO/Bg/II 
10 I-fo lland R635X/ R635X 14/14 Bg!H 
11 France R635X/ R.635X 14/14 Bg/U 
"The presence of the mutation in th e g:cnomic DNA was verified c ithet: by digestion 
with the restriction enzyme indicated or by allele-specific oligomer hybridization 
(ASO). 
!J T hese mutations poten tially lead to o ut-of-frame deletion of the exon indicated. 
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Figure 2. Identification of the putative splice site mutation 565-2A-> G in the LAMB3 gene in fan1ilics 1 and 2 (sec Table I) by heteroduplex 
analysis and restriction enzyme digestion. When exon 7 and fl anking intronic sequences were analyzed by CSGE, all three pro bands and the fa ther 
of family 1, as well as the parents of family 2, showed a similar he teroduplex band. T he mother's DNA in family 1 and the proband's and unaffected brother's 
DNA in family 2 showed a homoduplex band only (A). Direct sequencing demonstrated an A->G nucleotide substitution in posi tion - 2 in the 3' acceptor 
splice site of intron 6, which was fo und at the homozygous state in the proband of fam ily 2 (B top), and the proband in family 1 was heterozygous for this 
mutation w hen compared with the normal sequence (B middle, lower) . This substitution was recognized by the res triction endonuclease N laiV, which was used 
for verification of the mutation in these families. The normal allele corresponds to the 194-bp and 72-bp N lalV fra gments, and the 194-bp fragment is further 
digested to 123-bp and 71-bp fragments in the mutant allele (C) . 
enzyme digestion using the restnct1on endonucleases listed in Table I , 
fo llowed by analysis of the digestion products on agarose gels. In the 
absence of a change in restriction endonuclease sites, the PCR products 
corresponding to th e mutated region were analyzed with allele- specific 
o ligonucleotide hybridization, for which the amplified DNA fragments 
were blotted onto Zeta-Probe nylon membranes (Bio-Rad, Richmond, CA) 
and hybt;dized with y-32P-labeled oligonucleotides corresponding to the 
no rmal and mutated al leles (Dietz et a/, 1992). 
RESULTS 
Screening for the R635X Mutation in LAMB3 Mutation 
de tection strategies included first the screening for the presence of 
a recurrent mutation R635X in the DNA of H-JEB fa milies. For 
this purpose, the genomic segment corresponding to exon 14 was 
amplified and subj ected to restriction enzyme digestion with Bglll, 
as described earlier (Kivirikko et al, 1996). Tlus screening revealed 
that a total of 14 alleles of the 28 examined (50%) harbored the 
nonsense mutation R635X (Fig 1). Specifically, the probands in 
four families (fa.rnilies 7, 8, 10, and 11) were homozygous, and the 
pro bands in six fa milies (families 1, 3, 4, 5, 6, and 9) were 
heterozygous fo r tlus genetic lesion (Fig 1, Table 1) . 
Novel LAMB3 Mutations in H-JEB To identify other muta-
tions underlying the H-JEB phenotype in these fanlllies, the 
mutation detection strategy consisted of amplification of all exons 
ofLAMB3 gene, as well as amplification of all exons in the LAMC2 
gene in those probands who did not contain LAMB3 mutations in 
either allele. T he PCR products were examined in CSGE gel, 
followed by direct sequen cing of the PCR products containing 
he teroduplexes, and verifica tion of the mutations, as described in 
Materials and M ethods. T his strategy disclosed novel pathogenetic 
LAMB3 mutations in eight alle les (Table 1), whereas three pro-
bands (six all eles) were shown to harbor mutations in the LAMC2 
gene (Pulkki.nen et al, 1997c). T he novel mutations characterized in 
the eight alleles of the LAMB3 gene included three different 
nonsense mutations (R972X, Q243X, and C290X), two putative 
splicing mutations (565-2A--7G and 2910-1G--7A), and one 1-bp 
insertion (29insC). These mutations are described in detail in Figs 
2- 4. 
Consequences of the Mutations at the Protein Level To 
test for consequences of the LAMB3 mutations, indirect immuno-
fluorescence of the skin of the probands was performed with a 
battery of antibodies recognizing vatious cutaneous basement 
membrane zone epitopes. First, monoclonal antibody GB3 , which 
recog.uzes laminin 5 epitopes in the y2 chain when the protein is in 
native conformation, was used. In each fanlily tested (10 of11) GB3 
resulted in entirely negative stauung. T lus observation, wluch is in 
agreement w ith previous results on H-JEB (V errando et a/, 1991), 
indicates the absence of conformationally in tact lanunin 5 mole-
cules. 
A battery of additional antibodies for different basem ent mem-
brane zone epitopes were also used . Essentially normal staitung was 
achieved with antibodies recognizing the integrin a6 and {34 
subunits, the 180-kDa and the 230-kDa bullous pemplugoid anti-
gens, plectin/HD1, and type Vll collagen epitopes (results not 
shown). Similarly, normal immunofluorescence staining was ob-
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Figure 3. Hctcroduplcx analysis ofPCR products spanning cxon 20 and flanking intronic sequences ofLAMB3 in families 3 and 4 (A). The 
proband's and mother' s DNA in family 3, as well as proband's and father's DNA in family 4, showed heteroduplex bands that differed by mobility bet:\'Vcen 
the families (A). Direct sequencing of the proband's PCR product in family 3 revealed a G-A substitution in the last nucleotide of intron 19 (B 11ppe1). This 
putative splice site mutation was designated as 2910-lG-->A. Correspondingly, sequencing of the proband's PCR product off.~nuly 4 demonstrated a C->T 
transition within exon 20, resulting in the substitution of an arginine codon (CGA) with a stop codon (TGA) (B 111iddle) . T his nonsense mutation was 
designated as R972X. The corresponding normal sequence is also p1·esemed (lowe1). Restriction enzymes BsnJI and AlwNI were used for verification of these 
mutations (C). The mutation 2910-lG->A abolished a recognition site for Bscifl , and the 324-bp band, which corresponds to the mutant allele, is further 
digested to 214-bp and 11 0-bp bands in the normal allele. The mutation R972X created a new restriction enzyme site for A lwNl enzyme, which cuts the 
mutant allele to 207-bp and 117-bp bands, and the normal allele remains as an undigested band of 324 bp. 
served with a monoclonal antibody 123, which has been suggested 
to recognize an epitope in the linear IgA disease autoantigen 
(Marinkovich et al, 1996). Finally, immunofluorescence st.'lining 
with a monoclonal antibody 19-DEJ-1, recognizing the putative 
basement membrane zone autoantigen w"lcein was un.iform.ly neg-
ative in the skin of the seven pro bands tested. 
DISCUSSION 
]EB represents a group of both clinically and genetically heteroge-
neous diseases (Uitto and Christiano, 1992; Uitto et al , 1994; Uitto 
eta/, 1995; Christiano and Uitto, 1996; Uitto and Pulkkinen , 1996). 
On the basis of clinical observations, JEB is conventionally divided 
into the classic lethal (Herlitz) type and the nonlethal (non-Herlitz) 
fonns (Fine et al, 1991) . In the former group, the early dem..ise of 
affected individuals frequently occurs during the first year of life as 
a result of cutaneous and pulmonary complications. In the nonlethal 
forms, the lifespan of affected individuals is not usually compro-
mised, but the patients characteristically demonstrate a protracted 
blistering tendency associated with a variety of extracutaneous 
manifestations, including ocular and dental abnormalities. The 
phenotypic variability of]EB reflects the types and combinations of 
mutations in different candidate genes (Uitto et al, 1995; Chr;stiano 
and Uitto, 1996; Uitto and Pulkk.inen, 1996). Specific mutations 
have been disclosed thus far in seven different candidate genes 
encoding the components of the anchoring filament-hemidesmo-
some complex. 
The majority of mutations in JEB reside in the three genes, 
LAMA3 , LAMB3 and LAMC2, encoding the constitutive subunit 
polypeptides of lam.inin 5, the a3, {33, and y2 chains, respectively, 
and the maj01;ty of these mutations reside in LAMB3. The dispro-
portionately high percentage of genetic lesions in the LAMB3 gene 
is explained, at least in part, by the presence of two recurrent 
mutations R42X and R635X (Kiv.irikko et al, 1996) . The R42X 
mutation, reflecting a C-'>T transition at nucleotide position 124, 
has been disclosed in five alleles among the total of 56 H-JEB 
r.~mi lies examined thus far. More strikingly, however, the R635X 
mutation has been disclosed in a total of 39 alleles among these 
fanUli.es. In addition to these recurrent mutations, five other 
nonsense mutations substituting an arginine codon (CGA) with a 
stop codon (TGA) have been disclosed in LAMB3 in JEB pati.ents, 
including R972X discovered in this study. These particular arginine 
-'>stop codon mutations reflect C-'>T transitions at CpG dinucle-
otide sequences, most likely as a result of hypennutability of 
5-methylcytosine to thymine (Cooper and Youssoufian, 1988). 
These mutational hotspots have been detected in a vm:iety of genes 
underlying a number of hw"l1aJ1 diseases, including the dystrophic 
forms ofEB (see Hovnanim1 eta/, 1994) . Furthermore, attesting to 
the high frequency of arginine substitutions is the fact that approx-
imately 50% of cases with severe fonns of EB simplex m1d 
epidermolytic hyperkeratosis are due to keratin mutations involving 
arginine mutations (Corden et al, 1996). 
In tllis study, we have undertaken mutation analysis of14 fanlilies 
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Figure 4. Heteroduplex analysis ofPCR products spanning exons 3, 8, and 9 ofLAMB3 in families 5, 6, and 9 (A, D, G), respectively. The 
proband's DNA from £1 mily 5 demonstrated a heteroduplex band similar to that of her father (A) . Direct sequencing of the PCR product from the proband 
revealed an insertion of C in exon 3 (B 11ppe1) w hen compared with that of the normal allele (B lower). The mutation, designated as 29 insC, created a new 
restriction enzyme site for A lwNI, which cuts the nom1al allele of 498 bp to 351-bp and 148-bp bands in the mutant allel e (C). Sequencing of the proband 's 
PCR product spanning exon 8 in £1 mily 6, w hich demonstrated a heteroduplex band similar to that of her father (D), revealed a C-'>T transition when 
compared with the nonnal sequence (E). T his nonsense mutation, d esignated as Q243X, abolished the restri ction enzym e site for BsmFI, which cuts the 
normal allele to 207-bp and 200-bp fi·agments, and the mutant alle le remains as an undigested band of 407 bp (F). PCR. products spanning exon 9 from family 
9 demonstrated he teroduplexes with different mobilities in a CSGE gel (G) . The f.1ther had two closely migrating bands, and the mother had two distinct 
bands. Further, the pro bands' heteroduplex bands had slightly slower mobility compared with that of the m other 's (G). Sequencing of the PCR products from 
the fami ly m embers revealed tl1at the paternal mutation was a T-'> A transversion resulting in substitution of a cysteine codon (TGT) with a stop codon (TGA), which was designated as C290X (H). In addition , both probands had the ma ternal Nnrl po lymorphism in intron 9 (Pulkkinen el nl, 1995b; data not 
shown), explaining the diffe rent heteroduplex bands in tlus fiun il y. Alle le-specific oligonucleotide hybridization was used for verification of the patemal 
mutation C290X with the fo llowing oligonucleotides correspo ndi.ng to the normal and mutant all eles, respectively: 5 '- GCCCAAATTGIGAGCGCTGT- 3' 
and 5 ' - GCCCAAA TTGAGAGCGCTGT -3'. The results demonstrated that the mutant oligonucleotide hybridized to the PCR products from the fatl1er and 
the pro bands. The normal o ligom er also hybridized to tl1e mo ther's PCR product, confirnung the inheritan ce of tlu s mutation fro m the f.1ther (I). 
of European origin with at least one m ember affected with H-JEB . 
Among these families, 11 probands had both mutations in LAMB3 , 
and three probands harbored mutations in the LAMC2 gene. 
Among the 11 patients with genetic lesions in the LAMB3 gene, 4 
were homozygous for R635X, and 6 probands were compound 
heterozygotes with one allele containing R635X (Table 1). In the 
latter patients, however, the genetic lesion in the other allele in 
each case led to a premature termination codon, as the result of a 
nonsense mutation, a single nucleotide insertion, or a putative 
out-of-fra me exon skip mutation. These results underscore the 
prevalence of R63 5X and other stop codon mutations in H-JEB in 
families of European origin. Surprisingly, however , the mutations 
R635X and R42X w ere not found in a cohort of 12 Japanese JEB 
patients, suggesting ethnic differences in th e observed frequency of 
the mutations R42X and R635X (Shimizu et al , 1997). These kind 
of e thnic differences in mutation freq uency at specific CpG sites in 
other genes have been reported previously (Pattison et a/, 1990) . 
N evertheless, al.l H-JEB patients in which the mutations have been 
delineated thus fur have premature termination codon mutations in 
both alleles . These mutations, in addition to predicting synd1esis of 
a putative truncated polypeptide, can result in a markedly reduced 
level of the corresponding transcript due to accelerated nonsense-
mediated mRNA decay (Urlaub et al , 1989; Cui et a/, 1995). Thus, 
as a consequence of these pren1ature tern1inati.on codon mutations, 
no full-length lami.ni.n {33 chain polypeptides are synthesized . 
Because al.l three polypeptides, the a3, {33, and ')'2 chains, are 
required for the assembly of functi.onallami.ni.n 5 molecules (Burge-
son et nl, 1994), these mutations result in the absence oflami.n.i.n 5, 
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as reflected by negative immunofluorescence starnmg with anti-
lami.nin 5 antibodies, such as GB3 (Verra.ndo et al, 1991). In this 
context, it is important to emphasize that nonsense mutations in 
both a!Jeles of any of the three genes encoding the subunit 
polypeptides of lam in in 5 result in phenotypically indistinguishable 
disease, with early demise of the affected individuals usually v.rithin 
the first few months of the postnatal period. Tlus clinical similarity 
implies that a!J three chains of lamin.i.n 5 are equa!Jy important for 
the assembly of tlus protein and that there is no apparent substitu-
tion of the mutated chain by another functional polypeptide of tl1e 
lami11.in family. Because lanlliun 5 is the m;Uor component of 
anchoring filaments, the mutations result in the absence of these 
attachment structures in the H-JEB patients' skin and manifest 
cli.nica!Jy with extreme fragility and severe blistering tendency. 
Demonstration of the predominance of R635X in the LAM.B3 
gene has implications in terms of mutation detection strategy in 
Caucasian families with H-:JEB. Specifi.cally, the preponderance of 
this mutation suggests a stra tegy in wluch the patients are first 
screened for the presence of this particular genetic lesion . Tills can 
be readily accomplished by PCR amplification of exon 14, followed 
by restriction enzyme digestion v.ri.th Bglll . Carrier status of the 
parents and clinically unaffected individuals can be determined by 
the same strategy. If the patients do not demonstrate the presence 
of tlus nonsense mutation, it appears reasonable to screen them for 
mutations in LAM.B3 (Pulkkinen eta/, 1995b), fo!Jowed by LAMC2 
(Pulkkinen et al, 1997c) and LAMA3 (Kivirikko et a/, 1995). After 
identification of mutations in the proband v.ri.th H-JEB, tlus infor-
mation can be readily applied for prenatal testing from chorimuc 
villus specimens as early as the tenth week of gestation in fa111ilies 
at risk for recurrence of tlus devastating skin disease (Christiano et 
al , 1997). 
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